Your browser doesn't support javascript.
loading
The risk of QTc-interval prolongation in COVID-19 patients treated with chloroquine.
Sinkeler, F S; Berger, F A; Muntinga, H J; Jansen, M M P M.
Affiliation
  • Sinkeler FS; Department of Clinical Pharmacy, Elisabeth-TweeSteden Hospital, Tilburg, The Netherlands. f.sinkeler@etz.nl.
  • Berger FA; Department of Clinical Pharmacy, Meander Medical Centre, Amersfoort, The Netherlands.
  • Muntinga HJ; Department of Cardiology, Elisabeth-TweeSteden Hospital, Tilburg, The Netherlands.
  • Jansen MMPM; Department of Clinical Pharmacy, Elisabeth-TweeSteden Hospital, Tilburg, The Netherlands.
Neth Heart J ; 28(7-8): 418-423, 2020 Jul.
Article in En | MEDLINE | ID: mdl-32648153
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Etiology_studies / Observational_studies / Risk_factors_studies Language: En Journal: Neth Heart J Year: 2020 Document type: Article Affiliation country: Netherlands Country of publication: Netherlands
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Etiology_studies / Observational_studies / Risk_factors_studies Language: En Journal: Neth Heart J Year: 2020 Document type: Article Affiliation country: Netherlands Country of publication: Netherlands